Virginia Taylor, MD
Dermatology · Greenville, NCNPI 1720288442
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,833 of the $5,389 with a category attached, or 89.7%. 20 manufacturers reported payments, led by AbbVie at 31.5% of the total. Reporting peaked in 2023 at $1,258 and has fallen 57.8% since, to $530 in 2025.
Across 318 payments — averaging $16.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Johnson & Johnson$1K
- LEO Pharma Inc.$549
- Novartis$426
- Pfizer$364
- Lilly USA, LLC$301
- plus $1K from 14 others
What the payments were for
- Food & beverage$4,83390%
- Education$55710%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 112 | $1,700 |
| Johnson & Johnson | 58 | $1,047 |
| LEO Pharma Inc. | 36 | $549 |
| Novartis | 21 | $426 |
| Pfizer | 27 | $364 |
| Lilly USA, LLC | 18 | $301 |
| Regeneron Healthcare Solutions, Inc. | 8 | $227 |
| Sun Pharmaceutical Industries Inc. | 11 | $222 |
| Amgen | 5 | $120 |
| UCB, Inc. | 5 | $109 |
| Sanofi | 4 | $92 |
| E.r. Squibb & Sons, L.L.C. | 4 | $90 |
| Galderma Laboratories, L.p. | 2 | $32 |
| Pierre Fabre Pharmaceuticals, Inc. | 1 | $21 |
| Bristol Myers Squibb | 1 | $19 |
| Paratek Pharmaceuticals, Inc. | 1 | $15 |
| Genentech USA, Inc. | 1 | $14 |
| Organon | 1 | $14 |
| Boston Scientific | 1 | $14 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $13 |
How this compares
$5,389 in reported general payments places this provider in the 70th percentile of 475 dermatology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluorouracil | 181 | $13,509 |
| Tretinoin | 65 | $4,979 |
| Fluocinonide | 92 | $4,527 |
| Ivermectin | 14 | $4,390 |
| Metronidazole | 72 | $3,868 |
| Ketoconazole | 191 | $3,209 |
| Tacrolimus | 11 | $3,083 |
| Clobetasol Propionate | 56 | $2,669 |
| Mupirocin | 277 | $2,020 |
| Fluocinolone AcetonideFluocinolone/Shower Cap | 30 | $1,580 |
| Triamcinolone Acetonide | 136 | $1,428 |
| Clindamycin Phosphate | 26 | $1,159 |
| Doxycycline Hyclate | 45 | $819 |
| Hydrocortisone | 100 | $667 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 12 | $406 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Greenville
- Steven FeldmanWinston Salem$3.4M
- Nicole SeminaraHuntersville$1.4M
- Andrew LeeElkin$702K
- Christopher SayedChapel Hill$690K
- William HooverConcord$594K
- Patrick McElgunnCharlotte$565K
- George MagelHickory$554K
- Muneeb ShahClinton$451K
- John SoderbergCary$398K
- Rosalyn GeorgeWilmington$346K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.